Cytochrome P450 inhibitor, Cobicistat, Purity ≥98%

Cat. No.: X24-08-YM387

Cytochrome P450 inhibitor, Cobicistat, Purity ≥98%

Synonym: 1004316-88-4; GS9350; Cobicistatum; 1,3-Thiazol-5-ylmethyl N-[(2R,5R)-5-[[(2S)-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]-4-morpholin-4-ylbutanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate

  • MDL: MFCD18251449
  • CAS Number: 1004316-88-4
  • Compound CID: 25151504
Product Size
2 mg; 5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
Cobicistat, soluble in DMSO and ethanol and insoluble in water, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting cytochrome P450. It targets the CYP3A.
Molecular Weight
766
Molecular Formula
C40H53N7O5S2
Targets
CYP3A: 30-285 nM
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 85 mg/mL (109.53 mM); Water: insoluble; Ethanol: 85 mg/mL (109.53 mM); In vivo: 5% DMSO + 40% PEG 300 + ddH2O, 9 mg/mL
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Cobicistat is a metabolism inhibitor that can be used for its ability to increase the plasma levels of co-administered antiretroviral drugs, improving their effectiveness and reducing the frequency of dosing.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.